Gastrointestinal Support This peptide is a potent ally for your digestive system
No published research demonstrates superior outcomes from twice-daily versus once-daily Dihexa administration, and the compounds mechanism suggests more frequent dosing wouldnt necessarily enhance effects
It can irritate skin and aggravate your acne
Across the cagrilintide clinical program, the dominant tolerability issues have been gastrointestinal: nausea, reduced appetite, constipation, and, less commonly, vomiting a profile shared with pramlintide and with GLP-1 agonists, and mechanistically expected from a compound that slows the stomach and engages the area postrema
Our treatments provide a fast-acting energy boost, improved mood, and support for the nervous and immune systems
Appropriate activity modification during a protocol allows the peptide to work effectively while preventing setbacks from reinjury